The efficacy and prevalence of montelukast therapy in patients with allergic rhinitis

Mustafa Abdulrahman Ismaeel; Thamer Adnan Shaban; Layth Adnan Sulaiman

doi:10.53730/ijhs.v6nS3.9201

Authors

Mustafa Abdulrahman Ismaeel Department of Ear, Nose and Throat, Abu Ghraib General Hospital, Baghdad Alkarkh Health Directorate, Ministry of Health/Environment, Baghdad, Iraq
Thamer Adnan Shaban Department of Ear, Nose and Throat, Abu Ghraib General Hospital, Baghdad Alkarkh Health Directorate, Ministry of Health/Environment, Baghdad, Iraq
Layth Adnan Sulaiman
medicalresearch77@yahoo.com
Department of Ear, Nose and Throat, Abu Ghraib General Hospital, Baghdad Alkarkh Health Directorate, Ministry of Health/Environment, Baghdad, Iraq

Keywords:

allergic rhinitis, montelukast, chronic cough, sneezing, nasal congestion, rhinorrhea

Abstract

Allergic rhinitis is the most common atopic disorder seen in the outpatient clinic. Montelukast, is a novel medication, is an antagonist to the leukotriene receptor. The aim of this work was to identify the improvement in the severity of symptoms of child with AR treated with Montelukast. A cross-sectional study was conducted among fifty-patients with a chronic cough and (sneezing, nasal congestion, rhinorrhea, and postnasal drip) at least eight weeks using Montelukast between the periods of January 2019 to March 2019. By using the symptom severity score for AR, that calculated. Data including (age, gender, associated disease, exacerbation factors, and classical therapy). The dose of 10-mg Montelukast once daily was prescribed. On follow-up, after four-weeks, compliance was ensured and then the symptom severity score was recorded again. Most of patients aged above 40 years. Males to females ratio was 1:1.5. Most of patients (40, 80%) lived in urban regions. There was a reduction of the symptoms associated with RA after treatment with Montelukast.

Downloads

Download data is not yet available.

References

Lagos JA, Marshall GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007 Jun;3(2):327-32. doi: 10.2147/tcrm.2007.3.2.327. PMID: 18360641; PMCID: PMC1936314.

Rajput MSA, Arain AA, Rajput AA, Adeel M, Ghaffar S, Suahil A. Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis. Cureus. 2020 Mar 25;12(3):e7403. doi: 10.7759/cureus.7403. PMID: 32337129; PMCID: PMC7182046.

Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018, 14:31-41. 10.1186/s13223-018-0280-7.

Bourdin A, Gras D, Vachier I, Chanez P: Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax. 2009, 64:999-1004. 10.1136/thx.2008.112862.

Hirshon JM, Weiss SR, LoCasale R, Levine E, Blaisdell CJ. Looking beyond urban/rural differences: emergency department utilization by asthmatic children. J Asthma. 2006 May;43(4):301-6. doi: 10.1080/02770900600623255. PMID: 16809244..

Solé D, Cassol VE, Silva AR, Teche SP, Rizzato TM, Bandim LC, Sarinho ES, Camelo-Nunes IC. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among adolescents living in urban and rural areas in different regions of Brazil. Allergol Immunopathol (Madr). 2007 Nov-Dec;35(6):248-53. doi: 10.1157/13112991. PMID: 18047816.

Hedlund U, Rönmark E, Eriksson K, Lundbäck B, Järvholm B. Occupational exposure to dust, gases and fumes, a family history of asthma and impaired respiratory health. Scand J Work Environ Health. 2008 Oct;34(5):381-6. doi: 10.5271/sjweh.1284. PMID: 18956125.

Sun TY, Guo YF, Xu XM, Zhang HS, Hou J, Ke HX, Li YM, Fang BM, Ming SH. [The effect of Montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction]. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):83-7. Chinese. PMID: 15854387.

Stapleton M, Howard-Thompson A, George C, Hoover RM, Self TH. Smoking and asthma. J Am Board Fam Med. 2011 May-Jun;24(3):313-22. doi: 10.3122/jabfm.2011.03.100180. PMID: 21551404.

Wright MFA, Balfour-Lynn IM. Habit-tic cough: Presentation and outcome with simple reassurance. Pediatr Pulmonol. 2018 Apr;53(4):512-516. doi: 10.1002/ppul.23948. Epub 2018 Jan 24. PMID: 29363880.

Balter MS, Bell AD, Kaplan AG, Kim H, McIvor RA: Management of asthma in adults . CMAJ. 2009, 181:915-922. 10.1503/cmaj.080007

Peters M, Henderson WR: The role of leukotrienes in allergic rhinitis . Ann Allergy Asthma Immunol. 2005, 94:609-618. 10.1016/S1081-1206(10)61317-8

Ciebiada M, Gorska M, Barylski M, Kmiecik T, Gorski P: Use of Montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy. 2011, 25:1- 6. 10.2500/ajra.2011.25.3540

Cingi C, Gunhan K, Gage L, Unlu H: Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. Laryngoscope. 2010, 9:1718-1723. 10.1002/lary.20941

Al-Hamdani FY. Comparative clinical evaluation of ketotifen and Montelukast sodium in allergic rhinitistic Iraqi patients. Saudi Pharmaceutical Journal 2010 Oct; 18(4): 245–249. PMCID: PMC3730982. PMID:23960734. doi: [10.1016/j.jsps.2010.07.001].

Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Jan 17. PMID: 24741731.

Rinartha, K., & Suryasa, W. (2017). Comparative study for Gede Budasi, I. & Wayan Suryasa, I. (2021). The cultural view of North Bali community towards Ngidih marriage reflected from its lexicons. Journal of Language and Linguistic Studies, 17(3), 1484–1497

Suryasa, W. (2019). Historical Religion Dynamics: Phenomenon in Bali Island. Journal of Advanced Research in Dynamical and Control Systems, 11(6), 1679-1685.